RXRX - Recursion Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$5.90
DETAILS
HIGH:
$5.90
LOW:
$5.90
MEDIAN:
$5.90
CONSENSUS:
$5.90
UPSIDE:
59.46%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-10-06 | Borgeson Blake | director | SELL | 50,000 | $4.84 | $242K |
| 2026-10-06 | HERSHBERG ROBERT | director | M-Exempt | 25,000 | $2.22 | $56K |
| 2026-10-06 | HERSHBERG ROBERT | director | SELL | 25,000 | $5.00 | $125K |
| 2026-10-01 | Dar Zavain | director | A-Award | 4,607 | -- | -- |
| 2026-10-01 | Li Dean Y | director | A-Award | 3,378 | -- | -- |
| 2026-09-15 | Taylor Ben R | officer: Chief Financial Officer | F-InKind | 5,396 | $3.41 | $18K |
| 2026-09-08 | Khan Najat | director, officer: CEO and President | SELL | 22,408 | $3.52 | $79K |
| 2026-09-01 | Borgeson Blake | director | SELL | 30,000 | $3.34 | $100K |
| 2026-08-17 | Khan Najat | director, officer: CEO and President | F-InKind | 80,498 | $3.16 | $254K |
| 2026-08-17 | Hallett David | officer: Chief Scientific Officer | F-InKind | 26,657 | $3.16 | $84K |
| 2026-08-17 | Taylor Ben R | officer: Chief Financial Officer | F-InKind | 25,018 | $3.16 | $79K |
| 2026-08-04 | Borgeson Blake | director | SELL | 30,000 | $3.25 | $98K |
| 2026-07-07 | Borgeson Blake | director | SELL | 40,000 | $3.96 | $158K |
| 2026-07-01 | Dar Zavain | director | A-Award | 5,109 | -- | -- |
| 2026-07-01 | Li Dean Y | director | A-Award | 3,747 | -- | -- |
| 2026-06-17 | Borgeson Blake | director | A-Award | 88,424 | -- | -- |
| 2026-06-17 | HERSHBERG ROBERT | director | A-Award | 88,424 | -- | -- |
| 2026-06-17 | Michor Franziska | director | A-Award | 88,424 | -- | -- |
| 2026-06-17 | Sun Elaine D | director | A-Award | 88,424 | -- | -- |
| 2026-06-17 | Dar Zavain | director | A-Award | 88,424 | -- | -- |
| 2026-06-17 | Li Dean Y | director | A-Award | 88,424 | -- | -- |
| 2026-06-17 | Bumpus Namandje | director | A-Award | 88,424 | -- | -- |
| 2026-06-18 | Bumpus Namandje | director | SELL | 3,963 | $3.18 | $13K |
| 2026-06-15 | Taylor Ben R | officer: Chief Financial Officer | F-InKind | 5,396 | $3.15 | $17K |
| 2026-06-05 | Gibson Christopher | director | C-Conversion | 40,000 | -- | -- |